Evidence map›Paper›PMID 37693102›Full record

ArticleJournal of traditional and complementary medicine2023

Vitisin B, a resveratrol tetramer from

Yuh-Hwa Liu, Yin-Shiou Lin, Yi-Yan Sie, Ching-Chiung Wang, Chi-I Chang, Wen-Chi Hou

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of traditional and complementary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Antidiabetic Effects ofMarine drugs · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuh-Hwa LiuDepartment of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Yin-Shiou LinGraduate Institute of Pharmacognosy, Taipei Medical University, Taipei, 110, Taiwan.
Yi-Yan SiePh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Ching-Chiung WangPh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Chi-I ChangDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung, 912, Taiwan.
Wen-Chi HouGraduate Institute of Pharmacognosy, Taipei Medical University, Taipei, 110, Taiwan.
Taipei Medical University · TWNational Pingtung University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim: In Taiwan, Experimental procedure: The oral glucose tolerance test (OGTT) was used to imitate postprandial blood glucose (BG) regulations in mice by pre-treatment with VTT extracts, resveratrol tetramers of vitisin A, vitisin B, and hopeaphenol 30 min before glucose loads. Vitisin B (50 mg/kg) was administered to treat T2DM-ICR mice once daily for 28 days to investigate its hypoglycemic activity. Results and conclusion: Mice pre-treated with VTT-S-95EE, or vitisin B (100 mg/kg) 30-min before glucose loading showed significant reductions (

Indexed as

and hopeaphenolNutraceuticalsResveratrol tetramers of vitisin aType 2 diabetes mellitus (T2DM)Vitisin BVitis thunbergii var. taiwaniana (VTT)

Identifiers

PMID37693102
PMCPMC10491982
OpenAlexW4380142948

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.